Hospital
Integris South Oklahoma City Hospital Corporation
Integris South Oklahoma City Hospital Corporation was paid $38.62M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99283, emergency room visit (moderate) — 46% of everything it billed.
33Billing provider infoINTEGRIS SOUTH OKLAHOMA CITY HOSPITAL CORPORATION
OKLAHOMA CITY, OK 73109
OKLAHOMA CITY, OK 73109
33aNPI1457372625assigned 07/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$38.62M
24GClaims389,214
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#3 of 75
Median peer was paid$3.66M
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,329 | $4.25M | |
| 2019 | 48,410 | $5.16M | |
| 2020 | 34,595 | $3.84M | |
| 2021 | 55,640 | $5.58M | |
| 2022 | 77,427 | $7.34M | |
| 2023 | 84,577 | $8.06M | |
| 2024incomplete | 40,236 | $4.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 46% | 109,281 | 108,241 | $17.88M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 32,983 | 32,676 | $7.82M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 19,136 | 18,991 | $6.14M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.5% | 19,623 | 19,323 | $2.50M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 11,679 | 11,558 | $1.03M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 7,429 | 7,126 | $437K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 35,675 | 33,146 | $390K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 5,090 | 5,072 | $381K |
| 71045 | Radiologic examination, chest; single view | <1% | 17,918 | 17,741 | $251K |
| T1016 | Case management, each 15 minutes | <1% | 5,106 | 1,334 | $205K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,001 | 502 | $182K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,518 | 4,199 | $176K |
79 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,303 | $122K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 591 | $115K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 16,261 | $93K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,847 | $80K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,603 | $71K |
| 81025 | <1% | 9,419 | $69K | |
| 95811 | <1% | 220 | $66K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,893 | $62K |
| 85027 | <1% | 10,771 | $62K | |
| 81001 | <1% | 14,570 | $60K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 718 | $34K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 244 | $33K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,254 | $31K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 223 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 525 | $28K |
| 81003 | <1% | 13,409 | $28K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 135 | $23K |
| 87400 | <1% | 819 | $20K | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 12 | $12K |
| 84484 | <1% | 957 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 858 | $11K |
| 94060 | <1% | 423 | $10K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 209 | $10K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 52 | $10K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,392 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,316 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 94 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 61 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 639 | $7K |
| 83690 | <1% | 1,135 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,406 | $6K |
| 80143 | <1% | 300 | $5K | |
| 80179 | <1% | 298 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 147 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 147 | $4K |
| 94729 | <1% | 103 | $4K | |
| 94726 | <1% | 86 | $3K | |
| 71250 | <1% | 63 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 28 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 28 | $2K |
| 76801 | <1% | 26 | $2K | |
| 84703 | <1% | 186 | $1K | |
| 94150 | <1% | 57 | $1K | |
| 73130 | <1% | 40 | $735.85 | |
| 73610 | <1% | 40 | $701.35 | |
| 87430 | <1% | 39 | $564.10 | |
| 83615 | <1% | 75 | $403.00 | |
| 93017 | <1% | 13 | $351.44 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 130 | $341.84 |
| 82330 | <1% | 25 | $319.83 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 2,844 | $299.02 |
| 73110 | <1% | 13 | $246.72 | |
| 87070 | <1% | 24 | $180.08 | |
| 82728 | <1% | 14 | $169.68 | |
| 80051 | <1% | 14 | $164.92 | |
| 81002 | <1% | 53 | $161.90 | |
| 83550 | <1% | 15 | $116.55 | |
| 84156 | <1% | 33 | $107.93 | |
| 87210 | <1% | 26 | $106.68 | |
| 83540 | <1% | 15 | $86.25 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 63 | $65.80 |
| 82565 | <1% | 13 | $63.48 | |
| 82570 | <1% | 14 | $59.93 | |
| 85014 | <1% | 26 | $58.91 | |
| 84520 | <1% | 13 | $48.98 | |
| 82947 | <1% | 13 | $48.74 | |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | <1% | 16 | $35.91 |
| A4364 | Adhesive, liquid or equal, any type, per oz | <1% | 12 | $32.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 25 | $9.96 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 158 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 404 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 527 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 12 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 13 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,084 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 71 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 45 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMMES, CHRIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Integris Grove Hospital | Grove, OK | $3.41M |
| Integris Grove Hospital | Grove, OK | $1.96M |
| Integris Miami Hospital | Miami, OK | $1.44M |
| Integris Bass Baptist Health Center | Enid, OK | $1.11M |
| Integris Bass Baptist Health Center | Hennessey, OK | $264K |
| Integris Grove Hospital | Vinita, OK | $263K |
| Integris Miami Hospital | Miami, OK | $102K |
| Integris Bass Baptist Health Center | Caldwell, KS | $29K |
| Integris Bass Baptist Health Center | Enid, OK | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.